Table III.
Quality indicators focusing on choice of antibiotics (relevance for antimicrobial resistance).
| Quality indicators | Patients with acute sinusitis | Patients with acute otitis media | Patients with acute tonsillitis/pharyngitis | Patients with pneumonia | Patients with acute exacerbation of COPD | Patients with acute LRTI |
| Number of patients treated with narrow-spectrum penicillin | 85* (7) | 92* (7) | 96* (7) | 92* (7) | 62 (5) | 88* (7) |
| Number of patients treated with broad-spectrum penicillin +/-clavulanic acid | 92* (7) | 92* (7) | 92* (7) | 100* (7) | 92* (6) | 92* (7) |
| Number of patients treated with macrolides | 88* (7) | 85* (7) | 85* (7) | 88* (6) | 77* (6) | 88* (6.5) |
| Number of patients treated with cephalosporins | 81* (7) | 81* (7) | 88* (7) | 81* (6) | 73 (6) | 81* (7) |
| Number of patients treated with quinolones | 81* (7) | 81* (7) | 65 (6) | 81* (6.5) | 85* (6) | 81* (7) |
Notes: The values represent agreement rates 1 in% (median on a Likert scale, range 0-7). COPD =chronic obstructive pulmonary disease. LRTI =lower respiratory tract infection. *Consensus (agreement rate ≥75%). 1 Percentage of experts who scored the dimension ≥5 in the second Delphi round (n =26) on a Likert scale, range 1-7.